Literature DB >> 9644702

Cancer-related diarrhea: selected findings of a national survey of oncology nurse experiences.

D N Rutledge1, C Engelking.   

Abstract

PURPOSE/
OBJECTIVES: To describe oncology nurse experiences with disease- and treatment-related diarrhea in patients with cancer, including assessment methods and pharmacologic/supportive care.
DESIGN: Descriptive. SAMPLE/
SETTING: 1,288 (26%) of 5,000 randomly selected Oncology Nursing Society members employed full-time in adult clinical settings in the United States.
METHODS: Mailed survey with scannable booklets. MAIN RESEARCH VARIABLES: Nurse perceptions of disease and treatment-related issues associated with diarrhea in patients with cancer, along with currently used assessment criteria and nursing care.
FINDINGS: Nurses in this sample routinely encounter diarrhea in their patients with cancer. They commonly assess/document diarrhea by noting its presence or absence, with a minority of nurses using a rating tool. When indicated, most nurses prepare patients for probable diarrhea. This preparation includes both verbal and written instructions about diet, skin care, drug therapy, and treatment of severe diarrhea. Nurses report that primary drug therapy for diarrhea consists of over-the-counter agents. Supportive care consists of fluid/electrolyte replacement, skin care and diet modifications, and also bowel rest and parenteral nutrition for severe diarrhea. For these nurses, the most important factors influencing choice of management strategies are symptom relief and physician and patient preference.
CONCLUSIONS: Although the majority of nurses in this study report providing anticipatory guidance, patient education, and supportive diarrhea management, they are not assessing diarrhea systematically. They report common use of nonprescription medications, with pharmacologic interventions varying with severity of diarrhea. IMPLICATIONS FOR NURSING PRACTICE: Targeted education is needed to help nurses implement systematic assessment and documentation. Efficacy of diarrhea-management strategies and protocols must be tested-specifically, optimal timing and types of skin care, dietary changes, and bowel rest.

Entities:  

Mesh:

Year:  1998        PMID: 9644702

Source DB:  PubMed          Journal:  Oncol Nurs Forum        ISSN: 0190-535X            Impact factor:   2.172


  4 in total

Review 1.  Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage and prevention strategies.

Authors:  Rachel J Gibson; Dorothy M K Keefe
Journal:  Support Care Cancer       Date:  2006-04-08       Impact factor: 3.603

Review 2.  Mitigating acute chemotherapy-associated adverse events in patients with cancer.

Authors:  Nicole M Kuderer; Aakash Desai; Maryam B Lustberg; Gary H Lyman
Journal:  Nat Rev Clin Oncol       Date:  2022-10-11       Impact factor: 65.011

3.  A Nutritional Approach for the Management of Chemotherapy-Induced Diarrhea in Patients with Colorectal Cancer.

Authors:  Salvatore Artale; Nunziata Grillo; Stefano Lepori; Chiara Butti; Antonella Bovio; Sabrina Barzaghi; Andrea Colombo; Elena Castiglioni; Lucia Barbarini; Laura Zanlorenzi; Paola Antonelli; Riccardo Caccialanza; Paolo Pedrazzoli; Mauro Moroni; Sabrina Basciani; Rebecca Azzarello; Francesco Serra; Alessandra Trojani
Journal:  Nutrients       Date:  2022-04-26       Impact factor: 6.706

4.  Resolution of refractory chemotherapy-induced diarrhea (CID) with octreotide long-acting formulation in cancer patients: 11 case studies.

Authors:  Stephen Rosenoff
Journal:  Support Care Cancer       Date:  2004-05-25       Impact factor: 3.603

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.